Company · CIK 1855129

# GH Research PLC

| CIK | [1855129](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001855129) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | L2 |
| Business address | Ireland |
| Listed | GHRS (Nasdaq) |
| First annual or quarterly report | 2022-03-28 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-295872 | Shelf Effective | 2026-05-14 | 2026-05-19 | 2 |
| 333-285310 | Shelf Effective | 2025-02-27 | 2026-05-14 | 4 |
| 333-270418 | Shelf Effective | 2023-03-09 | 2025-02-05 | 4 |
| 333-256796 | IPO Final prospectus | 2021-06-04 | 2021-06-28 | 4 |

## Filings

 15

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-05-19 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1855129/999999999526001711/9999999995-26-001711-index.htm) Declared effective | 333-295872 | 9999999995-26-001711 |
| 2026-05-14 | [F-3](https://www.sec.gov/Archives/edgar/data/1855129/000114036126021176/0001140361-26-021176-index.htm) Shelf registered | 333-295872 | 0001140361-26-021176 |
| 2026-05-14 | [424B5](https://www.sec.gov/Archives/edgar/data/1855129/000114036126021169/0001140361-26-021169-index.htm) Shelf takedown | 333-285310 | 0001140361-26-021169 |
| 2026-04-29 | [424B5](https://www.sec.gov/Archives/edgar/data/1855129/000114036126017654/0001140361-26-017654-index.htm) Shelf takedown | 333-285310 | 0001140361-26-017654 |
| 2025-03-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1855129/999999999525000612/9999999995-25-000612-index.htm) Declared effective | 333-285310 | 9999999995-25-000612 |
| 2025-02-27 | [F-3](https://www.sec.gov/Archives/edgar/data/1855129/000114036125006178/0001140361-25-006178-index.htm) Shelf registered | 333-285310 | 0001140361-25-006178 |
| 2025-02-05 | [424B5](https://www.sec.gov/Archives/edgar/data/1855129/000114036125003183/0001140361-25-003183-index.htm) Shelf takedown | 333-270418 | 0001140361-25-003183 |
| 2025-02-03 | [424B5](https://www.sec.gov/Archives/edgar/data/1855129/000114036125002892/0001140361-25-002892-index.htm) Shelf takedown | 333-270418 | 0001140361-25-002892 |
| 2023-03-17 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1855129/999999999523000607/9999999995-23-000607-index.htm) Declared effective | 333-270418 | 9999999995-23-000607 |
| 2023-03-09 | [F-3](https://www.sec.gov/Archives/edgar/data/1855129/000095010323003906/0000950103-23-003906-index.htm) Shelf registered | 333-270418 | 0000950103-23-003906 |
| 2021-06-28 | [424B4](https://www.sec.gov/Archives/edgar/data/1855129/000114036121022509/0001140361-21-022509-index.htm) Final prospectus | 333-256796 | 0001140361-21-022509 |
| 2021-06-24 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1855129/999999999521002501/9999999995-21-002501-index.htm) Declared effective | 333-256796 | 9999999995-21-002501 |
| 2021-06-21 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1855129/000114036121021557/0001140361-21-021557-index.htm) Amendment | 333-256796 | 0001140361-21-021557 |
| 2021-06-04 | [F-1](https://www.sec.gov/Archives/edgar/data/1855129/000114036121019900/0001140361-21-019900-index.htm) Registration filed | 333-256796 | 0001140361-21-019900 |
| 2021-04-20 | [DRS](https://www.sec.gov/Archives/edgar/data/1855129/000114036121013456/0001140361-21-013456-index.htm) Draft made public | 377-04691 | 0001140361-21-013456 |

[All filings of this company](https://equitycapital.markets/filings?cik=1855129) · [CSV](https://equitycapital.markets/filings.csv?cik=1855129)

---
Source page: https://equitycapital.markets/company/1855129 · Data: U.S. SEC EDGAR · CC BY 4.0